#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Eosinophilic oesophagitis Ovarian cancer stage IV Anti-HLA antibody test positive Uveitis Squamous cell carcinoma of the vulva Deafness Congenital pseudarthrosis Immunodeficiency congenital Raynaud's phenomenon Methylmalonic acidaemia Gastrointestinal stromal tumour Ewing's sarcoma metastatic Glomerulonephritis chronic Congenital leptin deficiency Asthma More trials…

    Learn about Rare Diseases

    Hereditary motor and sensory neuropathy – Diagnostics Breast angiosarcoma – Life with Disease Glycogen storage disease type V – Life with Disease Glomerulonephritis membranous – Life with Disease Congenital nephrogenic diabetes insipidus – Treatment Mucopolysaccharidosis II – Diagnostics Niemann-Pick disease – Treatment Undifferentiated sarcoma Ewing’s sarcoma recurrent – Diagnostics Mantle cell lymphoma stage III – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Brigatinib Asfotase Alfa SODIUM DIHYDROGEN PHOSPHATE Enoxaparin Sodium Olorofim Lazertinib Canis Familiaris (553) Opelconazole TRIGLYCERIDES MEDIUM CHAIN Sodium Nitroprusside Dihydrate PRT3789 Soya-Bean Oil Refined Platelet Concentrate Ammonium Chloride Camlipixant Methylprednisolone Aceponate Brimonidine Tartrate VERT-002 Salbutamol Sulfate Ph. Eur. Montelukast More therapies…

    Learn about Your Condition

    Liver disorder Turner's syndrome Kaposi's sarcoma Carpal tunnel syndrome Transplantation complication Electronic cigarette user Iron overload Adenovirus infection Spondylolisthesis Cardiac amyloidosis Breast angiosarcoma metastatic Systemic mastocytosis Malignant melanoma of eyelid Crohn's disease Renal disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Spitalul Clinic Coltea

Spitalul Clinic Coltea

Bulevardul Bratianu C. Ion 1-3, Bucharest, 030171, Romania

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Mocravimod for Adults with Acute Myeloid Leukemia Undergoing Stem Cell Transplant

    Recruiting

    3 1
    Investigated Drugs:
    • Mocravimod
    France Germany Italy Poland Romania Spain

  • Study on the Effectiveness and Safety of Selinexor for Patients with Myelofibrosis and Moderate Thrombocytopenia Who Have Not Used JAK Inhibitors

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Aprepitant
    • Ondansetron
    • Pacritinib
    Belgium Bulgaria Czechia Denmark France Germany +7

  • Study on Human Normal Immunoglobulin and Sodium Chloride to Prevent Infections in Patients with Chronic Lymphocytic Leukemia

    Recruiting

    3 1 1
    Investigated Drugs:
    • Human Normal Immunoglobulin
    • Sodium Chloride
    Bulgaria Croatia Hungary Poland Romania

  • Study of human normal immunoglobulin and teclistamab for infection prevention in adults with multiple myeloma receiving B-cell maturation antigen therapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Human Normal Immunoglobulin
    • Teclistamab
    Austria Czechia Denmark Germany Greece Hungary +6

  • Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Ly3484356
    • Anastrozole
    • Exemestane
    Austria Belgium Czechia Finland France Germany +10

  • Study on the Safety of Ivosidenib and Azacitidine for Adults with Newly Diagnosed IDH1m Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Azacitidine
    • Ivosidenib
    Austria Belgium France Greece Hungary Ireland +5

  • Study of ianalumab for adults with primary immune thrombocytopenia or warm-antibody autoimmune hemolytic anemia who previously responded to ianalumab

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Warm autoimmune haemolytic anaemia
    • Immune thrombocytopenia
    Investigated Drugs:
    • Danazol
    • Entecavir
    • Ianalumab
    Belgium Bulgaria Czechia France Germany Hungary +3

  • Study of romiplostim for treating low platelet counts caused by chemotherapy in adults with non-small cell lung cancer, ovarian cancer, or breast cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Thrombocytopenia
    • Breast cancer
    • Non-small cell lung cancer
    Investigated Drugs:
    • Romiplostim
    Greece Poland Portugal Romania Spain

  • Testing Drug Combinations with GSK4381562A, GSK6097608, GSK4428859 and Dostarlimab in Patients with PD-L1 Positive Head and Neck Cancer That Has Spread or Returned

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Gsk4381562A
    • Gsk6097608
    • Human Igg1 Kappa Monoclonal Antibody Against Tigit
    Denmark Finland France Germany Greece Hungary +6

  • Study of Quizartinib with Chemotherapy for Adults with Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Quizartinib Dihydrochloride
    • Idarubicin Hydrochloride
    • Daunorubicin Hydrochloride
    Austria Belgium Bulgaria Croatia Czechia France +9
Previous Page
1 2 3 4 5
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!